laz-20240425
0001311370FALSE00013113702024-04-252024-04-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________________
FORM 8-K
________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 25, 2024
________________________________________________
Lazard, Inc.
(Exact name of registrant as specified in its charter)
________________________________________________
Delaware001-3249298-0437848
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)(IRS Employer
Identification No.)
30 Rockefeller Plaza
New York, New York
10112
(Address of Principal Executive Offices)(Zip Code)
Registrant’s Telephone Number, Including Area Code: 212-632-6000
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per shareLAZNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 2.02    Results of Operations and Financial Condition.
On April 25, 2024, Lazard, Inc. (the “Company”) issued a press release announcing financial results for its first quarter ended March 31, 2024. A copy of the Company’s press release containing this information is being furnished as Exhibit 99.1 to this Report on Form 8-K and is incorporated herein by reference.
The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
Item 9.01    Financial Statements and Exhibits.
(d)Exhibits. The following exhibits are filed or furnished as part of this Report on Form 8-K:
Exhibit
Number
Description
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
LAZARD, INC.
(Registrant)
By:/s/ Shari Soloway
Name:Shari Soloway
Title:Corporate Secretary
Dated: April 25, 2024

Document

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg

LAZARD REPORTS FIRST-QUARTER 2024 RESULTS
Record first-quarter firm-wide adjusted net revenue
Record first-quarter Financial Advisory adjusted net revenue
Asset Management quarter end AUM increased 8% year-over-year

NEW YORK, April 25, 2024 – Lazard, Inc. (NYSE: LAZ) today reported net revenue of $765 million and adjusted net revenue1 of $747 million for the quarter ended March 31, 2024. On a U.S. GAAP basis, first-quarter 2024 net income was $36 million or $0.35 per share, diluted. Adjusted net income2 was $67 million, or $0.66 per share, diluted, for the quarter.

“Lazard’s record first-quarter revenue reflects an improving M&A environment and reinforces our outlook for a productive year ahead, as we continue to make strides in executing our long-term strategic plan,” said Peter R. Orszag, Chief Executive Officer, Lazard. “This quarter’s strong results also reflect our ability to deliver diversified asset management solutions for our clients while evolving the business into newer areas of opportunity. With increasing momentum across the firm, we remain focused on serving clients, winning new business, and delivering long-term value for our shareholders.”



(Selected results, $ in millions,Quarter Ended
except per share data and AUM)March 31,
U.S. GAAP Financial Measures20242023%'24-'23
Net Revenue$765 $542 41 %
Financial Advisory$454 $278 63 %
Asset Management$295 $284 %
Net Income (Loss)$36 ($22)NM
Per share, diluted$0.35 ($0.27)NM
Adjusted Financial Measures1, 2
Net Revenue$747 $527 42 %
Financial Advisory$447 $274 63 %
Asset Management$276 $265 %
Net Income (Loss)$67 ($23)NM
Per share, diluted$0.66 ($0.26)NM
Assets Under Management ($ in billions)
Ending AUM$250 $232 %
Average AUM$247 $227 %
Media Contact:
Shannon Houston+1 212 632 6880shannon.houston@lazard.com
Investor Contact:Alexandra Deignan+1 212 632 6886alexandra.deignan@lazard.com
Note: Endnotes are on page 4 of this release. Reconciliations of U.S. GAAP to Adjusted results are shown on pages 10-12.
1

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
NET REVENUE
Financial Advisory
Financial Advisory net revenue and adjusted net revenue1 were $454 million and $447 million, respectively, for the first quarter of 2024, both 63% higher than the first quarter of 2023.

During and since the first quarter of 2024, Lazard has been engaged in significant and complex M&A transactions globally, including the following (clients are in italics): Orange on the combination of its and Masmovil’s operations in Spain, with a combined enterprise value of €18.6 billion; ImmunoGen’s $10.1 billion acquisition by AbbVie; CymaBay Therapeutic’s $4.3 billion acquisition by Gilead; Vitesco Technologies' €3.0 billion merger agreement with Schaeffler; Saint-Gobain's AUD 4.5 billion agreement to acquire CSR Limited in Australia; LXi’s £1.8 billion merger with LondonMetric; Hotel Chocolat's £570 million acquisition by a subsidiary of Mars, Inc.; Blue Stream Fiber’s investment from Sixth Street Partners; IBM’s sale of The Weather Company assets to Francisco Partners; Pagero on the company's SEK 8.1 billion sale to Thomson Reuters; Officine Maccaferri's sale to Ambienta SGR; QuattroR's acquisition of a 50% controlling stake in Massimo Zanetti Beverage Group and Terra-Gen on the announced sale of a 50% stake in the company held by Energy Capital Partners to Masdar.
Lazard's preeminent restructuring and liability management practices have been engaged in a broad range of complex restructuring and debt advisory assignments, including company roles involving Enviva, Inversiones Latin America Power and Tele Columbus and creditor and/or related party roles involving AFE, Avison Young, Endo Pharmaceuticals, Hilding Anders, JOANN, Loparex, Lumen Technologies, Orpea, Rite Aid and SVB Financial Group.

Our capital advisory and solutions practices remain active and engaged in assignments, including Wynnchurch Capital on the closing of its $3.5 billion Fund VI, Rubicon Founders on the closing of its ~$1.2 billion second healthcare fund, McCarthy Capital on the closing of its $870 million private equity fund and Sodexo in connection with the €3.8 billion listing of Pluxee on Euronext Paris following its spin-off from the company. Our sovereign advisory practice continues to be active in advising governments and sovereign entities across developed and emerging markets.
For a list of publicly announced transactions please visit our website.











2

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
Asset Management
Asset Management net revenue and adjusted net revenue1 were $295 million and $276 million, respectively, for the first quarter of 2024, both 4% higher than the first quarter of 2023.
Management fees and other revenue, on an adjusted basis1, were $268 million, 3% and 4% higher, respectively, than the first quarter of 2023 and fourth quarter of 2023.
Incentive fees, on an adjusted basis1 during the period were $8 million, compared to $5 million for the first quarter of 2023.
Average assets under management (AUM) for the first quarter of 2024 were $247 billion, 9% higher than the first quarter of 2023, and 6% higher than the fourth quarter of 2023.
AUM as of March 31, 2024, was $250 billion, 2% higher than December 31, 2023 and 8% higher than March 31, 2023. The sequential change from December 31, 2023 was driven by market appreciation of $14.0 billion, foreign exchange depreciation of $3.6 billion and net outflows of $6.6 billion.
OPERATING EXPENSES
Compensation and Benefits
For the first quarter of 2024, compensation and benefits expense on a U.S. GAAP and adjusted basis1 were $551 million and $493 million, respectively, compared to $450 million and $399 million, respectively, for the first quarter of 2023. The adjusted compensation ratio3 for the first quarter of 2024 was 66.0%, compared to the first-quarter 2023 ratio of 75.7%.
We focus on the adjusted compensation ratio to manage costs, balancing a view of current conditions in the market for talent alongside our objective to drive long-term shareholder value. Our goal remains to deliver an adjusted compensation ratio over the cycle in the mid- to high-50s percentage range, while targeting a consistent deferral policy.
Non-Compensation Expenses
For the first quarter of 2024, non-compensation expenses on a U.S. GAAP and adjusted basis1 were $159 million and $134 million, both 6% lower than the first quarter of 2023, primarily reflecting lower professional services and other expenses.
The adjusted non-compensation ratio4 was 18.0% for the first quarter of 2024, compared to 27.0% for the first quarter of 2023.
Our goal remains to deliver an adjusted non-compensation ratio between 16% to 20% over the cycle.
TAXES
The provisions for income taxes, on a U.S. GAAP and adjusted basis1 were $14 million and $32 million, respectively, for the first quarter of 2024. The effective tax rate on an adjusted basis1 was 32.6% for the first quarter of 2024, compared to 32.1% for the first quarter of 2023.
3

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            

CAPITAL MANAGEMENT AND BALANCE SHEET
In the first quarter of 2024, we issued $400 million of 6.0% Senior Notes due March 2031 to refinance the upcoming maturity of our 2025 Senior Notes.
In the first quarter of 2024, Lazard returned $121 million to shareholders, which included: $44 million in dividends; $22 million in share repurchases of our common stock; and $56 million in satisfaction of employee tax obligations in lieu of share issuances upon vesting of equity grants.
In the first quarter of 2024, we repurchased 0.6 million shares at an average price of $38.97. As of March 31, 2024, our remaining share repurchase authorization was $178 million.
On April 24, 2024, Lazard declared a quarterly dividend of $0.50 per share on its outstanding common stock. The dividend is payable on May 17, 2024, to stockholders of record on May 6, 2024.
Lazard’s financial position remains strong. As of March 31, 2024, our cash and cash equivalents were $923 million.




ENDNOTES
Beginning in the first quarter of 2024, Lazard has updated the names of certain non-U.S. GAAP ("non-GAAP") measures and metrics. The nomenclature change did not result in any change to the components of our non-GAAP measures and metrics compared to prior periods. Reconciliations of U.S. GAAP to Adjusted results are shown on pages 10-12.
1A non-GAAP measure. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for the corresponding U.S. GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. See attached financial schedules and related notes for a detailed explanation of adjustments to corresponding U.S. GAAP results. We believe that presenting our results on an adjusted basis, in addition to the U.S. GAAP results, is a meaningful and useful way to compare our operating results across periods.
2First-quarter 2024 adjusted results1 exclude pre-tax charges of $48.7 million relating to expenses associated with cost-saving initiatives. Including the effect of taxes, these resulted in a net charge of $30.9 million, or $0.31, per share, diluted, for the first quarter of 2024.
3The adjusted compensation ratio is based on a calculation where the numerator is adjusted compensation and benefits expense and the denominator is adjusted net revenue.
4The adjusted non-compensation ratio is based on a calculation where the numerator is adjusted non-compensation expense and the denominator is adjusted net revenue.

4

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
CONFERENCE CALL
Lazard will host a conference call at 8:00 a.m. ET on April 25, 2024, to discuss the company’s financial results for the first quarter of 2024. The conference call can be accessed via a live audio webcast available through Lazard’s Investor Relations website at www.lazard.com, or by dialing 1 800-343-4136 (toll-free, U.S. and Canada) or +1 203-518-9843 (outside of the U.S. and Canada), 15 minutes prior to the start of the call. Conference ID: LAZQ124.
A replay of the conference call will be available by 10:00 a.m. ET, April 25, 2024, via the Lazard Investor Relations website at www.lazard.com, or by dialing +1 800-753-9197 (toll-free, U.S. and Canada) or +1 402-220-0689 (outside of the U.S. and Canada).
ABOUT LAZARD
Founded in 1848, Lazard is one of the world's preeminent financial advisory and asset management firms, with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. For more information, please visit www.lazard.com.
Cautionary Note Regarding Forward-Looking Statements:
This press release contains forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “target,” “goal,” or “continue,” and the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our strategies, business plans and initiatives and anticipated trends in our business. These forward-looking statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by these forward-looking statements.
These factors include, but are not limited to, those discussed in our Annual Report on Form 10-K under Item 1A “Risk Factors,” and also discussed from time to time in our reports on Forms 10-Q and 8-K, including the following:
A decline in general economic conditions or the global or regional financial markets;
A decline in our revenues, for example due to a decline in overall mergers and acquisitions (M&A) activity, our share of the M&A market or our assets under management (AUM);
Losses caused by financial or other problems experienced by third parties;
Losses due to unidentified or unanticipated risks;
A lack of liquidity, i.e., ready access to funds, for use in our businesses; and
Competitive pressure on our businesses and on our ability to retain and attract employees at current compensation levels
In the event of a change or adverse interpretation of relevant income tax law, regulation or treaty, or a failure to qualify for treaty benefits, or in the event tax authorities challenge our tax computations or classifications.
Although we believe the statements reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, achievements or events. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this release to conform our prior statements to actual results or revised expectations and we do not intend to do so.
Lazard, Inc. is committed to providing timely and accurate information to the investing public, consistent with our legal and regulatory obligations. To that end, Lazard and its operating companies use their websites, and other social media sites to convey information about their businesses, including the anticipated release of quarterly financial results, quarterly financial, statistical and business-related information, and the posting of updates of assets under management in various mutual funds, hedge funds and other investment products managed by Lazard Asset Management LLC and Lazard Frères Gestion SAS. Investors can link to Lazard and its operating company websites through www.lazard.com.
***
LAZ-EPE
5

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                                            
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(U.S. GAAP - unaudited)
Three Months Ended% Change From
March 31,December 31,March 31,December 31,March 31,
($ in thousands, except per share data)20242023202320232023
Total revenue$785,481 $825,763 $561,911 (5%)40%
Interest expense(20,728)(19,742)(19,475)
Net revenue764,753 806,021 542,436 (5%)41%
Operating expenses:
Compensation and benefits550,824 559,207 449,967 (1%)22%
Occupancy and equipment 32,857 33,436 31,773 
Marketing and business development23,599 27,259 22,762 
Technology and information services44,917 47,363 44,040 
Professional services19,880 23,129 24,326 
Fund administration and outsourced services26,140 27,450 26,576 
Amortization and other acquisition-related costs68 95 48 
Other11,907 19,644 20,303 
Non-compensation expenses159,368 178,376 169,828 (11%)(6%)
   Benefit pursuant to tax receivable agreement– (3,459)(40,435)
Operating expenses710,192 734,124 579,360 (3%)23%
Operating income (loss)54,561 71,897 (36,924)(24%)NM
Provision (benefit) for income taxes14,337 403 (21,725)NMNM
Net income (loss)40,224 71,494 (15,199)(44%)NM
Net income attributable to noncontrolling interests4,469 7,927 6,973 
Net income (loss) attributable to Lazard, Inc.$35,755 $63,567 ($22,172)(44%)NM
Attributable to Lazard, Inc. Common Stockholders:
Weighted average shares outstanding:
         Basic91,260,465 90,228,532 87,591,852 1%4%
         Diluted99,351,769 94,989,330 87,591,852 5%13%
Net income (loss) per share:
         Basic$0.38$0.69($0.27)(45%)NM
         Diluted$0.35$0.65($0.27)(46%)NM


Note: For the three month periods ended March 31, 2024, December 31, 2023 and March 31, 2023, Financial Advisory net revenue was $453,507, $489,258 and $277,574, respectively; Asset Management net revenue was $295,476, $294,284 and $284,044, respectively; Corporate net revenue (loss) was $15,770, $22,479 and ($19,182), respectively.
6

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
CONDENSED CONSOLIDATED
STATEMENT OF FINANCIAL CONDITION
(U.S. GAAP - unaudited)
March 31,December 31,
($ in thousands)20242023
ASSETS
Cash and cash equivalents$923,247$971,316 
Deposits with banks and short-term investments247,847219,576 
Restricted cash33,55834,091 
Receivables750,483762,319 
Investments620,615701,964 
Property227,539232,516 
Goodwill and other intangible assets394,113394,928 
Operating lease right-of-use assets389,884407,213 
Deferred tax assets506,171497,340 
Other assets493,513414,518 
Total Assets$4,586,970$4,635,781 
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS & STOCKHOLDERS' EQUITY
Liabilities
Deposits and other customer payables$536,343 $443,262 
Accrued compensation and benefits495,923 781,375 
Operating lease liabilities467,351 485,191 
Tax receivable agreement obligation115,001 115,087 
Senior debt1,851,444 1,690,200 
Other liabilities583,902 550,804 
Total liabilities4,049,964 4,065,919 
Commitments and contingencies  
Redeemable noncontrolling interests88,475 87,675 
Stockholders' equity  
Preferred stock, par value $.01 per share– – 
Common stock, par value $.01 per share1,128 1,128 
Additional paid-in capital134,573 247,204 
Retained earnings1,384,829 1,402,636 
Accumulated other comprehensive loss, net of tax(303,995)(289,950)
Subtotal1,216,535 1,361,018 
Class A common stock held by subsidiaries, at cost(823,821)(937,259)
Total Lazard, Inc. stockholders' equity392,714 423,759 
Noncontrolling interests55,817 58,428 
Total stockholders' equity448,531 482,187 
Total liabilities, redeemable noncontrolling interests and stockholders' equity$4,586,970 $4,635,781 

Note: "Property" includes $71 million and $73 million of property held for sale at March 31, 2024 and December 31, 2023, respectively.
7

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
SELECTED SUMMARY FINANCIAL INFORMATION (a)
(Adjusted Basis - Non-GAAP - unaudited)
Three Months Ended% Change From
March 31,December 31,March 31,December 31,March 31,
($ in thousands, except per share data)20242023202320232023
Net Revenue:
Financial Advisory$446,634$477,366$273,861(6%)63%
Asset Management275,934273,694264,6451%4%
Corporate 23,9979,898(11,488)142%NM
Adjusted net revenue (b) $746,565$760,958$527,018(2%)42%
Expenses:
Adjusted compensation and benefits expense (c)$492,733$515,724$399,090(4%)23%
Adjusted compensation ratio66.0 %67.8 %75.7 %
Adjusted non-compensation expenses (d) $134,293$148,119$142,258(9%)(6%)
Adjusted non-compensation ratio18.0 %19.5 %27.0 %
Earnings:
Adjusted operating income (loss) (e)$119,539$97,115($14,330)23%NM
Adjusted operating margin (f)16.0 %12.8 %(2.7 %)
Adjusted net income (loss) (g)$66,606$65,011($22,948)2%NM
Adjusted diluted net income (loss) per share$0.66$0.66($0.26)–%NM
Adjusted diluted weighted average shares (h)101,532,21999,154,02187,591,8522%16%
Adjusted effective tax rate (i)32.6 %16.0 %32.1 %

This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for the corresponding U.S. GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. For a detailed explanation of the adjustments made to the corresponding U.S. GAAP measures, see Reconciliation of U.S. GAAP to Selected Summary Financial Information and Notes to Financial Schedules.
8

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
ASSETS UNDER MANAGEMENT
(unaudited)

($ in millions)As of  % Change From
March 31,December 31,March 31,December 31,March 31,
20242023202320232023
Equity:
Emerging Markets$24,779$25,288 $23,692 (2.0%)4.6%
Global55,54453,528 49,797 3.8%11.5%
Local54,84152,208 49,887 5.0%9.9%
Multi-Regional60,08959,114 55,252 1.6%8.8%
Total Equity195,253190,138 178,628 2.7%9.3%
Fixed Income:
Emerging Markets9,0809,525 9,164 (4.7%)(0.9%)
Global10,66410,762 11,322 (0.9%)(5.8%)
Local6,3786,080 6,002 4.9%6.3%
Multi-Regional21,09821,740 18,973 (3.0%)11.2%
Total Fixed Income47,22048,107 45,461 (1.8%)3.9%
Alternative Investments3,2013,330 4,111 (3.9%)(22.1%)
Other Alternative Investments2,6432,799 2,479 (5.6%)6.6%
Private Equity 1,4861,623 821 (8.4%)81.0%
Cash Management629654 640 (3.8%)(1.7%)
Total AUM$250,432$246,651 $232,140 1.5%7.9%
Three Months Ended% Change From
  March 31,December 31,March 31,December 31,March 31,
20242023202320232023
AUM - Beginning of Period$246,651$228,264 $216,125 
Net Flows(6,630)(3,550)2,999 
Market and foreign exchange
    appreciation10,41121,937 13,016 
AUM - End of Period$250,432$246,651 $232,140 
Average AUM$246,950$233,949 $226,849 5.6%8.9%

Note: Average AUM generally represents the average of the monthly ending AUM balances for the period.
9

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
RECONCILIATION OF U.S. GAAP TO ADJUSTED RESULTS (a)
(unaudited)


Three Months Ended
March 31,December 31,March 31,
($ in thousands, except per share data)202420232023
Net Revenue
Financial Advisory net revenue - U.S. GAAP Basis$453,507 $489,258 $277,574 
Adjustments:
(Gains) losses associated with cost-saving initiatives (j)587 (340)– 
Reimbursable deal costs, bad debt expense and other (k)(7,501)(11,581)(3,781)
Interest expense41 29 68 
Adjusted Financial Advisory net revenue$446,634 $477,366 $273,861 
Asset Management net revenue - U.S. GAAP Basis$295,476 $294,284 $284,044 
Adjustments:
Revenue related to noncontrolling interests (l)(4,097)(3,392)(4,002)
Distribution fees and other (k)(15,448)(17,201)(15,400)
Interest expense
Adjusted Asset Management net revenue$275,934 $273,694 $264,645 
Corporate net revenue (loss) - U.S. GAAP Basis$15,770 $22,479 ($19,182)
Adjustments:
Revenue related to noncontrolling interests (l)(3,006)(6,843)(6,821)
Gains related to Lazard Fund Interests ("LFI") and other similar arrangements(9,373)(25,933)(16,453)
Bad debt expense (k)– – (7,500)
Asset impairment charges– – 19,129 
Losses associated with cost-saving initiatives (j)– 571 – 
Interest expense20,606 19,624 19,339 
Adjusted Corporate net revenue (loss)$23,997 $9,898 ($11,488)
Net revenue - U.S. GAAP Basis$764,753 $806,021 $542,436 
Adjustments:
Revenue related to noncontrolling interests (l)(7,103)(10,235)(10,823)
Gains related to Lazard Fund Interests ("LFI") and other similar arrangements(9,373)(25,933)(16,453)
Distribution fees, reimbursable deal costs, bad debt expense and other (k)(22,949)(28,782)(26,681)
Asset impairment charges– – 19,129 
Losses associated with cost-saving initiatives (j)587 231 – 
Interest expense20,650 19,656 19,410 
Adjusted net revenue (b)$746,565 $760,958 $527,018 




This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for the corresponding U.S. GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. For a detailed explanation of the adjustments made to the corresponding U.S. GAAP measures, see Notes to Financial Schedules.
See Notes to Financial Schedules
10

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
RECONCILIATION OF U.S. GAAP TO ADJUSTED RESULTS (a)
(unaudited)

Three Months Ended
March 31,December 31,March 31,
($ in thousands, except per share data)202420232023
Compensation and Benefits Expense
Compensation and benefits expense - U.S. GAAP Basis$550,824 $559,207 $449,967 
Adjustments:
Charges pertaining to LFI and other similar arrangements(9,373)(25,933)(16,453)
Expenses associated with cost-saving initiatives (m)(46,610)(15,814)(20,740)
Expenses associated with senior management transition (n)– – (10,674)
Compensation related to noncontrolling interests (l)(2,108)(1,736)(3,010)
Adjusted compensation and benefits expense (c)$492,733 $515,724 $399,090 
Non-Compensation Expense
Non-compensation expenses - U.S. GAAP Basis$159,368 $178,376 $169,828 
Adjustments:
Expenses associated with cost-saving initiatives (m)(1,532)(807)– 
Distribution fees, reimbursable deal costs, bad debt expense and other (k)(22,949)(28,782)(26,681)
Amortization and other acquisition-related costs(68)(95)(48)
Non-compensation expense related to noncontrolling interests (l)(526)(573)(841)
Adjusted non-compensation expenses (d)$134,293 $148,119 $142,258 
Operating Income (Loss)
Operating income (loss) - U.S. GAAP Basis$54,561 $71,897 ($36,924)
Adjustments:
Benefit pursuant to tax receivable agreement obligation ("TRA") (o)– (3,459)(40,435)
Asset impairment charges– – 19,129 
Losses associated with cost-saving initiatives (j)587 231 – 
Expenses associated with cost-saving initiatives (m)48,142 16,621 20,740 
Expenses associated with senior management transition (n)– – 10,674 
Net income related to noncontrolling interests (l)(4,469)(7,927)(6,973)
Interest expense20,650 19,656 19,410 
Amortization and other acquisition-related costs68 96 49 
Adjusted operating income (loss) (e)$119,539 $97,115 ($14,330)
Provision for Income Taxes
Provision (benefit) for income taxes - U.S. GAAP Basis$14,337 $403 ($21,725)
Adjustments:
Tax effect of adjustments17,878 11,949 10,884 
Adjusted provision (benefit) for income taxes$32,215 $12,352 ($10,841)
Net Income attributable to Lazard, Inc.
Net income (loss) attributable to Lazard, Inc. - U.S. GAAP Basis$35,755 $63,567 ($22,172)
Adjustments:
Benefit pursuant to tax receivable agreement obligation ("TRA") (o)– (3,459)(40,435)
Asset impairment charges– – 19,129 
Losses associated with cost-saving initiatives (j)587 231 – 
Expenses associated with cost-saving initiatives (m)48,142 16,621 20,740 
Expenses associated with senior management transition (n)– – 10,674 
Tax effect of adjustments(17,878)(11,949)(10,884)
Adjusted net income (loss) (g)$66,606 $65,011 ($22,948)
Diluted Weighted Average Shares Outstanding
Diluted Weighted Average Shares Outstanding - U.S. GAAP Basis99,351,769 94,989,330 87,591,852 
Adjustment: participating securities including profits interest participation rights and other2,180,450 4,164,691 – 
Adjusted Diluted Weighted Average Shares Outstanding (h)101,532,219 99,154,021 87,591,852 
Diluted net income (loss) per share:
U.S. GAAP Basis$0.35 $0.65 ($0.27)
Adjusted Basis$0.66 $0.66 ($0.26)
This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for the corresponding U.S. GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. For a detailed explanation of the adjustments made to the corresponding U.S. GAAP measures, see Notes to Financial Schedules.
See Notes to Financial Schedules
11

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            
RECONCILIATION OF NON-COMPENSATION U.S. GAAP TO ADJUSTED (a)
(unaudited)
Three Months Ended
March 31,December 31,March 31,
($ in thousands)202420232023
Non-compensation expenses - U.S. GAAP Basis:
Occupancy and equipment $32,857 $33,436 $31,773 
Marketing and business development23,599 27,259 22,762 
Technology and information services44,917 47,363 44,040 
Professional services19,880 23,129 24,326 
Fund administration and outsourced services26,140 27,450 26,576 
Amortization and other acquisition-related costs68 95 48 
Other11,907 19,644 20,303 
Non-compensation expenses - U.S. GAAP Basis$159,368 $178,376 $169,828 
Non-compensation expense - Adjustments:
Occupancy and equipment (l) (m)($1,573)($197)($61)
Marketing and business development (k) (l)(2,079)(3,748)(2,728)
Technology and information services (k) (l) (m)(35)(149)(73)
Professional services (k) (l) (m)(873)(1,306)(1,402)
Fund administration and outsourced services (k) (l)(15,035)(16,546)(14,979)
Amortization and other acquisition-related costs(68)(95)(48)
Other (k) (l) (m)(5,412)(8,216)(8,279)
Subtotal non-compensation adjustments($25,075)($30,257)($27,570)
Adjusted non-compensation expenses:
Occupancy and equipment $31,284 $33,239 $31,712 
Marketing and business development21,520 23,511 20,034 
Technology and information services44,882 47,214 43,967 
Professional services19,007 21,823 22,924 
Fund administration and outsourced services11,105 10,904 11,597 
Amortization and other acquisition-related costs– – – 
Other6,495 11,428 12,024 
Adjusted non-compensation expenses (d)$134,293 $148,119 $142,258 


This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for the corresponding U.S. GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. For a detailed explanation of the adjustments made to the corresponding U.S. GAAP measures, see Notes to Financial Schedules.
See Notes to Financial Schedules
12

https://cdn.kscope.io/1512d06445d4d233a4b5ab9005b5d328-lazard_corporatexbluea.jpg                            

LAZARD, Inc.
Notes to Financial Schedules
(a)Selected Summary Financial Information are non-GAAP measures. Lazard believes that presenting results and measures on an adjusted basis in conjunction with U.S. GAAP measures provides a meaningful and useful basis for comparison of its operating results across periods. Beginning in the first quarter of 2024, Lazard has updated the names of certain non-GAAP measures and metrics. The nomenclature change did not result in any change to the components of our non-GAAP measures and metrics compared to prior periods.
(b)A non-GAAP measure which excludes (i) revenue related to non-controlling interests (see (l) below), (ii) gains related to the changes in the fair value of investments held in connection with Lazard Fund Interests and other similar deferred compensation arrangements for which a corresponding equal amount is excluded from compensation & benefits expense, (iii) revenue related to distribution fees, reimbursable deal costs in accordance with the revenue recognition guidance, bad debt expense, and other (see (k) below), (iv) for the three month period ended March 31, 2023, asset impairment charges, (v) for the three month periods ended March 31, 2024 and December 31, 2023, losses associated with cost-saving initiatives (see (j) below), and (vi) interest expense primarily related to corporate financing activities.
(c)A non-GAAP measure which excludes (i) charges related to the changes in the fair value of the compensation liability recorded in connection with Lazard Fund Interests and other similar deferred compensation arrangements, (ii) expenses associated with cost-saving initiatives (see (m) below), (iii) for the three month period ended March 31, 2023, expenses associated with senior management transition (see (n) below), and (iv) compensation and benefits related to noncontrolling interests (see (l) below).
(d)A non-GAAP measure which excludes (i) for the three month periods ended March 31, 2024 and December 31, 2023, expenses associated with cost-saving initiatives (see (m) below), (ii) expenses related to distribution fees, reimbursable deal costs in accordance with the revenue recognition guidance, bad debt expense, and other (see (k) below), (iii) amortization and other acquisition-related costs, and (iv) expenses related to noncontrolling interests (see (l) below).
(e)A non-GAAP measure which excludes (i) for the three month periods ended December 31, 2023 and March 31, 2023, a benefit pursuant to tax receivable agreement obligation ("TRA") (see (o) below), (ii) for the three month period ended December 31, 2023, asset impairment charges, (iii) for the three month periods ended March 31, 2024 and December 31, 2023, losses associated with cost-saving initiatives (see (j) below), (iv) expenses associated with cost-saving initiatives (see (m) below), (v) for the three month period ended December 31, 2023, expenses associated with senior management transition (see (n) below), (vi) net revenue and expenses related to noncontrolling interests (see (l) below), (vii) interest expense primarily related to corporate financing activities, and (viii) amortization and other acquisition-related costs.
(f)A non-GAAP measure which represents adjusted operating income as a percentage of adjusted net revenue.
(g)A non-GAAP measure which excludes (i) for the three month periods ended December 31, 2023 and March 31, 2023, a benefit pursuant to tax receivable agreement obligation (see (o) below), (ii) for the three month period ended December 31, 2023, asset impairment charges, (iii) for the three periods ended March 31, 2024 and December 31, 2023, losses associated with cost-saving initiatives (see (j) below), (iv) expenses associated with cost-saving initiatives (see (m) below), and (v) for the three month period ended December 31, 2023, expenses associated with senior management transition (see (n) below), net of tax benefits.
(h)A non-GAAP measure which includes units of the long-term incentive compensation program consisting of profits interest participation rights, which are equity incentive awards that, subject to certain conditions, may be exchanged for shares of our common stock. Certain profits interest participation rights and other participating securities may be excluded from the computation of outstanding stock equivalents for U.S. GAAP net income per share. In addition, for the three month periods ended March 31, 2024 and December 31, 2023, includes dilutive effect of weighted average number of incremental shares of common stock issuable from share-based incentive compensation.
(i)Adjusted effective tax rate is a non-GAAP measure based upon the U.S. GAAP rate with adjustments for the tax applicable to the non-GAAP adjustments to operating income (loss), generally based upon the effective marginal tax rate in the applicable jurisdiction of the adjustments. The calculation is based on a ratio where the numerator is the adjusted provision (benefit) for income taxes of $32,215, $12,352, and ($10,841) for the three month periods ended March 31, 2024, December 31, 2023, and March 31, 2023, respectively, and the denominator is adjusted operating income (loss) less interest expense and amortization and other acquisition-related costs of $98,820, $77,363, and ($33,789) for the three month periods ended March 31, 2024, December 31, 2023, and March 31, 2023, respectively.
(j)Represents losses associated with the closing of certain offices as part of the cost-saving initiatives including the reclassification of currency translation adjustments to earnings from accumulated other comprehensive loss and transactions related to foreign currency exchange.
(k)Represents certain distribution, introducer and management fees paid to third parties and reimbursable deal costs for which an equal amount is excluded from both adjusted net revenue and adjusted non-compensation expense, respectively, and excludes bad debt expense, which represents fees and other receivables that are deemed uncollectible.
(l)Noncontrolling interests include revenue and expenses principally related to Edgewater, ESC Funds and a Special Purpose Acquisition Company.
(m)Represents expenses associated with cost-saving initiatives including closing certain offices.
(n)Represents expenses associated with senior management transition reflecting the departure of certain executive officers.
(o)Pursuant to the periodic revaluation of the TRA liability and the assumptions reflected in the estimate, the revaluation had the effect of reducing the estimated liability under the TRA. As a result, the Company recorded a “benefit pursuant to tax receivable agreement” of $3,459 for the three month period ended December 31, 2023 and $40,435 for the three month period ended March 31, 2023.
NMNot meaningful
13